NextPlat (NXPL) Profit After Tax (2010 - 2026)
NextPlat's (NXPL) quarterly Profit After Tax came in at -$150000.0 in Q2 2026, up 91.88% year-over-year from -$78174.4 in Q2 2025, and up 86.75% quarter-over-quarter from -$1.1 million in Q1 2026.
Analysis
NextPlat (NXPL) Profit After Tax (2010 - 2026) Analysis & Trends
NextPlat (NXPL) has reported Profit After Tax for 16 consecutive years, with -$150000.0 the latest figure, recorded in Q2 2026.
- On a quarterly basis, Profit After Tax rose 91.88% year-over-year to -$150000.0 in Q2 2026; TTM through Jun 2026 was -$8.6 million, a 37.78% increase from a year earlier, with the FY2025 full-year figure at -$10.5 million, up 53.33% from the prior year.
- Profit After Tax was -$150000.0 for Q2 2026 at NextPlat, up from -$1.1 million in the prior quarter.
- Over five years, Profit After Tax peaked at $3.4 million in Q3 2023 and troughed at -$10.7 million in Q2 2024.
- A 5-year average of -$3.1 million and a median of -$1.9 million in 2025 frame the typical range for Profit After Tax.
- The widest YoY moves for Profit After Tax: up 159.64% in 2023, down 960.32% in 2023.
- Over 5 years, Profit After Tax stood at -$898027.0 in 2022, then slumped by 960.32% to -$9.5 million in 2023, then surged by 74.89% to -$2.4 million in 2024, then tumbled by 115.27% to -$5.1 million in 2025, then soared by 97.09% to -$150000.0 in 2026.
- The last three Profit After Tax figures came in at -$150000.0 (Q2 2026), -$1.1 million (Q1 2026), and -$5.1 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.34 Bn | 38.68 Bn | 2.15 Bn | -576.00 Mn |
| 2 | Viatris | 19.39 Bn | 18.50 Bn | 1.46 Bn | -118.80 Mn |
| 3 | Dr Reddys Laboratories | 9.99 Bn | 9.85 Bn | 396.53 Mn | 45.93 Mn |
| 4 | Amneal Pharmaceuticals | 5.57 Bn | 5.53 Bn | 334.51 Mn | 69.61 Mn |
| 5 | Bausch Health Companies | 2.45 Bn | 1.58 Bn | 2.10 Bn | 260.00 Mn |
| 6 | Ani Pharmaceuticals | 1.70 Bn | 1.34 Bn | 165.89 Mn | 24.71 Mn |
| 7 | Alvotech | 1.66 Bn | 1.52 Bn | 2.56 Mn | -66.82 Mn |
| 8 | Amphastar Pharmaceuticals | 985.90 Mn | 695.77 Mn | 93.47 Mn | 30.35 Mn |
| 9 | Fennec Pharmaceuticals | 434.07 Mn | 392.82 Mn | 17.15 Mn | 1.97 Mn |
| 10 | NextPlat | 24.77 Mn | 12.93 Mn | 4.69 Mn | -150,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -150,000.00 |
| Mar 31, 2026 | -1.13 Mn |
| Dec 31, 2025 | -5.15 Mn |
| Sep 30, 2025 | -2.19 Mn |
| Jun 30, 2025 | -1.85 Mn |
| Mar 31, 2025 | -1.94 Mn |
| Dec 31, 2024 | -2.39 Mn |
| Sep 30, 2024 | -7.66 Mn |
| Jun 30, 2024 | -10.74 Mn |
| Mar 31, 2024 | -1.70 Mn |
| Dec 31, 2023 | -9.52 Mn |
| Sep 30, 2023 | 3.45 Mn |
| Jun 30, 2023 | -4.34 Mn |
| Mar 31, 2023 | -1.19 Mn |
| Dec 31, 2022 | -898,027.00 |
| Sep 30, 2022 | -5.78 Mn |
| Jun 30, 2022 | -1.66 Mn |
| Mar 31, 2022 | -850,083.00 |
| Dec 31, 2021 | -3.54 Mn |
| Sep 30, 2021 | -2.31 Mn |